PetMed Express, Inc. Financials

Market Capitalization $102.1 Million as of Jan. 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	1191.00
Forward PE	-402.00
Price to Sales TTM	$0.31
Price to Book MRQ	$0.82
Enterprise to Revenue	0.12
Enterprise to EBITDA	7.93

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-03-31
Most Recent Quarter	2023-12-31
Profit Margin	-0.96%
Operating Margin	-4.71%
Return on Assets TTM	-0.68%
Return on Equity TTM	-2.28%

Income Statement

Revenue TTM	$276,967,008
Revenue per Share TTM	$13.60
Quarterly Revenue Growth	11.00%
Gross Profit TTM	$71,014,000
EBITDA	$2,116,000
Net Income to Common TTM	$-2,664,000
Diluted EPS TTM	$-0.37
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$49,440,000
Total Cash per Share MRQ	$2.42
Total Debt MRQ	$
Total Debt to Equity MRQ	1.64
Current Ratio MRQ	1.32
Book Value per Share MRQ	$4.90

Cash Flow

Operating Cash Flow TTM	$6,916,000
Levered Free Cash Flow TTM	$32,707,124

PETS Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	21,148,700
Float Shares	18,119,293
Avg 10 Volume	386,290
Avg 30 Volume	None
Shares Short	4,556,915
Short Ratio	12.51
Short % of Shares	26.95%
% Held by Insiders	4.42%
% Held by Institutions	75.13%

Stock Price Summary

Beta	0.70
Fifty Two Week Low	$3.92
Fifty Two Week High	$16.18
Fifty Two Week Change	-266.67%
Day 50 MA	$4.71
Day 200 MA	$8.21

Dividends and Splits

Forward Annual Dividend Rate	$1.20
Forward Annual Dividend Yield	29.63%
Trailing Annual Dividend Rate	$0.60
Trailing Annual Dividend Yield	14.81%
Payout Ratio	12000.00%
Dividend Date	2023-08-18
Ex Dividend Date	2023-08-11
Last Split Factor
Last Split Date